Cargando…

Capsomer Vaccines Protect Mice from Vaginal Challenge with Human Papillomavirus

Capsomers were produced in bacteria as glutathione-S-transferase (GST) fusion proteins with human papillomavirus type 16 L1 lacking the first nine and final 29 residues (GST-HPV16L1Δ) alone or linked with residues 13–47 of HPV18, HPV31 and HPV45 L2 in tandem (GST-HPV16L1Δ-L2x3). Subcutaneous immuniz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Wai-Hong, Gersch, Elizabeth, Kwak, Kihyuck, Jagu, Subhashini, Karanam, Balasubramanyam, Huh, Warner K., Garcea, Robert L., Roden, Richard B. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206079/ https://www.ncbi.nlm.nih.gov/pubmed/22069498 http://dx.doi.org/10.1371/journal.pone.0027141

Ejemplares similares

Optimization of Multimeric Human Papillomavirus L2 Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2013)

Role of L2 cysteines in papillomavirus infection and neutralization
por: Gambhira, Ratish, et al.
Publicado: (2009)

Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
por: Kwak, Kihyuck, et al.
Publicado: (2014)

Multivalent Human Papillomavirus L1 DNA Vaccination Utilizing Electroporation
por: Kwak, Kihyuck, et al.
Publicado: (2013)

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009)

Molecular Dynamics Simulations of Deformable Viral Capsomers
por: Nilsson, Lauren B., et al.
Publicado: (2023)

Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
por: Wang, Joshua W., et al.
Publicado: (2014)

Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
por: Kalnin, Kirill, et al.
Publicado: (2017)

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+ Cancer
por: Peng, Shiwen, et al.
Publicado: (2015)

Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach
por: Wu, Wai-Hong, et al.
Publicado: (2015)

Sublingual Immunization of Trivalent Human Papillomavirus DNA Vaccine in Baculovirus Nanovector for Protection against Vaginal Challenge
por: Lee, Hee-Jung, et al.
Publicado: (2015)

B cell memory: building two walls of protection against pathogens
por: Akkaya, Munir, et al.
Publicado: (2019)

Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
por: Nieto, Karen, et al.
Publicado: (2012)

Human papillomavirus: The other invisible enemy
por: Abel, Mary Kathryn, et al.
Publicado: (2020)

Increased B Cell Understanding Puts Improved Vaccine Platforms Just Over the Horizon
por: Notario, Geneva Rose, et al.
Publicado: (2022)

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice
por: Gallay, Philippe A., et al.
Publicado: (2018)

The role of human papillomavirus testing after treatment for high-grade cervical dysplasia
por: Turner, Taylor B, et al.
Publicado: (2016)

Human papillomavirus in vulvar and vaginal carcinoma cell lines
Publicado: (1995)

Human papillomavirus in vulvar and vaginal carcinoma cell lines.
por: Hietanen, S., et al.
Publicado: (1995)

Vaginal microbiota and human papillomavirus: a systematic review
por: Mortaki, Despoina, et al.
Publicado: (2020)

Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases
por: Olczak, Pola, et al.
Publicado: (2020)

Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia
por: Lamos, Cristina, et al.
Publicado: (2016)

Immunizing against Anogenital Cancer: HPV Vaccines
por: Pogoda, Cloe S., et al.
Publicado: (2016)

Challenging Vaginal Discharge, Lactobacillosis and Cytolytic Vaginitis
por: Ventolini, Gary, et al.
Publicado: (2022)

Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study
por: Zhou, Fang-Yue, et al.
Publicado: (2020)

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
por: Huh, Warner K., et al.
Publicado: (2014)

Molecular Diagnosis of Human Papillomavirus: Comparison Between Cervical and Vaginal Sampling
por: Finan, Ramzi R., et al.
Publicado: (2001)

Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
por: Coorevits, Liselotte, et al.
Publicado: (2018)

Vaginal microbiota and human papillomavirus infection among young Swedish women
por: Cheng, Liqin, et al.
Publicado: (2020)

Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection
por: Wei, Zhen-Tong, et al.
Publicado: (2021)

Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection
por: Ntuli, Lungelo, et al.
Publicado: (2022)

Roles of vaginal flora in human papillomavirus infection, virus persistence and clearance
por: Zeng, Mi, et al.
Publicado: (2023)

The interplay between human papillomavirus and vaginal microbiota in cervical cancer development
por: Sharifian, Kimia, et al.
Publicado: (2023)

Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers
por: Arora, Ritu, et al.
Publicado: (2015)

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
por: Brown, Darron R., et al.
Publicado: (2022)

Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology
por: Garcea, Robert L., et al.
Publicado: (2020)

Association of the Vaginal Microbiota with Human Papillomavirus Infection in a Korean Twin Cohort
por: Lee, Jung Eun, et al.
Publicado: (2013)

Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection
por: So, Kyeong A., et al.
Publicado: (2020)

The Replicative Consequences of Papillomavirus E2 Protein Binding to the Origin Replication Factor ORC2
por: DeSmet, Marsha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5h6plr7ln7cfhs93pjitodc5qi